Dr. Nicholas Richardson is a recognized expert in pediatric hematology and oncology, with deep regulatory and clinical development experience in cell and gene therapies. Formerly Deputy Director at the FDA’s Division of Hematologic Malignancies, he played a pivotal role in advancing CAR-T therapies, bispecifics, and T-cell engagers. At Precision for Medicine, Dr. Richardson leads clinical development efforts, guiding life sciences companies through complex regulatory landscapes and accelerating innovative trial designs. His work focuses on transforming blood cancer treatment and advancing biomarker-driven approaches to cell and gene therapy.